Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grignani

Showing results (491-500 of 688) with videos related to

Pageof 69
Sort By:
Leukemia|April 29, 1998
Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion proteinU Testa, F Grignani, H J Hassan, et al.
Toxics|December 24, 2025
Human Exposure to Metals and Potential Human Health Risk in a Volcanic Environment in ItalyGiovanni Forte, Venerando Rapisarda, Flavia Ruggieri, et al.
Cell Death and Differentiation|October 22, 2013
Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitorsL Vian, M Di Carlo, E Pelosi, et al.
Frontiers in Oncology|May 12, 2020
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GISTAnnalisa Astolfi, Valentina Indio, Margherita Nannini, et al.
Pediatric Blood & Cancer|June 15, 2017
Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma GroupRoberto Luksch, Giovanni Grignani, Paolo D'Angelo, et al.
Molecular Medicine (Cambridge, Mass.)|August 15, 2017
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer CellsGiulia Mesiano, Roberta Zini, Giulia Montagner, et al.
Minerva Chirurgica|June 1, 1997
[Hypertonic saline solutions in resuscitation in hemorrhagic shock. An experimental study]O Chiara, M Segala, D Volpi, et al.
Cell Death and Differentiation|August 11, 2007
deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiationS Mainardi, A Pelosi, E Palescandolo, et al.
Oncogene|June 30, 2015
PML is required for telomere stability in non-neoplastic human cellsM Marchesini, R Matocci, L Tasselli, et al.
Sarcoma|March 29, 2016
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced AngiosarcomaGaetano Apice, Antonio Pizzolorusso, Massimo Di Maio, et al.
Pageof 69

Showing results (491-500 of 688) with videos related to

Sort By:
Pageof 69
Leukemia|April 29, 1998
Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion proteinU Testa, F Grignani, H J Hassan, et al.
Toxics|December 24, 2025
Human Exposure to Metals and Potential Human Health Risk in a Volcanic Environment in ItalyGiovanni Forte, Venerando Rapisarda, Flavia Ruggieri, et al.
Cell Death and Differentiation|October 22, 2013
Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitorsL Vian, M Di Carlo, E Pelosi, et al.
Frontiers in Oncology|May 12, 2020
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GISTAnnalisa Astolfi, Valentina Indio, Margherita Nannini, et al.
Pediatric Blood & Cancer|June 15, 2017
Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma GroupRoberto Luksch, Giovanni Grignani, Paolo D'Angelo, et al.
Molecular Medicine (Cambridge, Mass.)|August 15, 2017
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer CellsGiulia Mesiano, Roberta Zini, Giulia Montagner, et al.
Minerva Chirurgica|June 1, 1997
[Hypertonic saline solutions in resuscitation in hemorrhagic shock. An experimental study]O Chiara, M Segala, D Volpi, et al.
Cell Death and Differentiation|August 11, 2007
deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiationS Mainardi, A Pelosi, E Palescandolo, et al.
Oncogene|June 30, 2015
PML is required for telomere stability in non-neoplastic human cellsM Marchesini, R Matocci, L Tasselli, et al.
Sarcoma|March 29, 2016
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced AngiosarcomaGaetano Apice, Antonio Pizzolorusso, Massimo Di Maio, et al.
Pageof 69